UPDATE 1 — China's InnoCare, Eli Lilly sign collaboration deal worth up to $3.35 billion
(Updates with details on licensing deal) Sept 24 (Reuters) — Chinese drugmaker InnoCare Pharma said on Thursday it had entered into a research collaboration and licensing agreement with Eli Lilly worth up to about $3.35 billion. Here are some more details: InnoCare would receive up to $100 million in upfront and near-t